Maxis Clinical Sciences
↗Edison, United States
Maxis Clinical Sciences is a global integrated research competence center and specialized management consulting organization serving the pharmaceutical and life sciences sectors. The company provides strategic advisory services, functional service provider (FSP) models, clinical biometrics, and digital health solutions, with a focus on patient-centricity and outcome-driven clinical development.
Founded in 2022, the firm operates as a strategic partner to small and medium-sized enterprises, leveraging advanced technologies like AI and real-world data analytics to streamline clinical trials, enhance data management, and accelerate drug development processes.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Research Consulting & Digital Health
SIZE & FINANCIALS
Employees:201-500
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Unfunded
Total Raised:$0
0
CORPORATE STRUCTURE
Key Partnerships:Pharmaceutical and life sciences companies (clients)
COMPETITION
Position:Niche Player
Competitors:Pharmaron, Pfizer, Boehringer Ingelheim
LEADERSHIP
Key Executives:
Divya Reddy - Founder & President
Harbrinder Ghumman - Chief People Officer
Dr. Kavita Lamror - Partner, RWE & Digital Transformation
LINKS
Website:maxisclinical.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Maxis Clinical Sciences and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Maxis Clinical Sciences. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.